Catherine is Director of Market Access at Vitaccess.
She supports our clients to identify and deliver value, by providing direction to the design and delivery of our digital real-word evidence studies and consulting work.
Catherine brings to the team over 10 years’ experience in market access, pricing and reimbursement. She has particular interests in primary research, value-proposition development, and pricing and reimbursement assessment, including the review and tracking of health technology assessments. Catherine is experienced in applying the Delphi Panel methodology to investigate treatment patterns and healthcare resource use in rare diseases.
Catherine has led the development of innovative interactive tools and projects in a variety of disease areas, including autoimmune disease, hepatitis, oncology, and rheumatology. She has contributed to a number of publications, spanning subjects such as market access challenges of drugs for rare diseases and the role of RWE in HTA for orphan drugs.
Prior to joining Vitaccess, Catherine gained experience in market access consultancy at a leading contract research organization, and as a medical and economic writer.
Catherine has a BA in Biology from Oxford University and an MRes in Molecular Biotechnology from Imperial College London.
Catherine lives in Brighton with her family and loves scuba diving.